Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Inflammation-mediated Phenoconversion: A Potential Threat to COVID-19 Pharmacotherapy

HAYATI Journal of Biosciences · Vol. 28 No. 1 (2021)

DOI
10.4308/hjb.28.1.54
ISSN
2086-4094, 1978-3019
Terbit
2021-01-01
Penerbit
Bogor Agricultural University, Indonesia
Bahasa
eng

Abstrak

One of the important hallmarks of coronavirus disease 2019 (COVID-19) is the existence of severe inflammatory responses. Many reports indicated that inflammatory mediators might suppress the biological functions of some drug metabolizing enzymes and transporters, and therefore result in a transient mismatch between their genotype and phenotype expressions, a phenomenon which is called phenoconversion. The incidence might be clinically relevant to the COVID-19 patients with comorbidities. The patients are treated with multiple drugs that are prone to be altered pharmacokinetically by inflammation-mediated phenoconversion, leading to the modification of their effectiveness and safety. In this review, we discuss the regulation of inflammatory responses during COVID-19 infection and the evidence as well as potential mechanisms of inflammation-mediated phenoconversion. We also provide possible clinical implications of such phenoconversion events as a potential threat in the management of COVID-19 patients.

Jaringan kolaborasi para penulis

17 penulis · 51 tautan kepenulisan bersama · 16 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Hasanuddin University
  • Kanazawa University
  • University of Groningen
  • Universitas Syiah Kuala
  • Universitas Setia Budi
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Sartini SartiniHasanuddin University2
M. Natsir DjideHasanuddin University2
Rangga Meidianto AsriHasanuddin University1
Gemini AlamHasanuddin University1
Muhammad AhsanHasanuddin University1
Rudi ArfiansyahHasanuddin University1
Subehan SubehanHasanuddin University1
Tri Puspita RoskaHasanuddin University1
Emil SalimKanazawa University1
Takayuki KuraishiKanazawa University1
I. IchsanAfiliasi tidak diketahui1
W. WienandsAfiliasi tidak diketahui1
Ana IndrayatiUniversitas Setia Budi1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://journal.ipb.ac.id/index.php/hayati/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Inflammation-mediated Phenoconversion: A Potential Threat to COVID-19 Pharmacotherapy</dc:title>
	<dc:creator xml:lang="en">Bahar, Muh. Akbar </dc:creator>
	<dc:creator xml:lang="en">Wilffert, Bob </dc:creator>
	<dc:creator xml:lang="en">Harapan, Harapan </dc:creator>
	<dc:creator xml:lang="en">Nainu, Firzan </dc:creator>
	<dc:description xml:lang="en">One of the important hallmarks of coronavirus disease 2019 (COVID-19) is the existence of severe inflammatory responses. Many reports indicated that inflammatory mediators might suppress the biological functions of some drug metabolizing enzymes and transporters, and therefore result in a transient mismatch between their genotype and phenotype expressions, a phenomenon which is called phenoconversion. The incidence might be clinically relevant to the COVID-19 patients with comorbidities. The patients are treated with multiple drugs that are prone to be altered pharmacokinetically by inflammation-mediated phenoconversion, leading to the modification of their effectiveness and safety. In this review, we discuss the regulation of inflammatory responses during COVID-19 infection and the evidence as well as potential mechanisms of inflammation-mediated phenoconversion. We also provide possible clinical implications of such phenoconversion events as a potential threat in the management of COVID-19 patients.</dc:description>
	<dc:publisher xml:lang="en">Bogor Agricultural University, Indonesia</dc:publisher>
	<dc:date>2021-01-01</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>http://journal.ipb.ac.id/hayati/article/view/35303</dc:identifier>
	<dc:identifier>10.4308/hjb.28.1.54</dc:identifier>
	<dc:source xml:lang="en">HAYATI Journal of Biosciences; Vol. 28 No. 1 (2021): January 2021; 54</dc:source>
	<dc:source>2086-4094</dc:source>
	<dc:source>1978-3019</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>http://journal.ipb.ac.id/hayati/article/view/35303/21447</dc:relation>
</oai_dc:dc>